DECITABINE for Bone marrow conditioning regimen: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 34 adverse event reports in the FDA FAERS database where DECITABINE was used for Bone marrow conditioning regimen.
Most Reported Side Effects for DECITABINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 336 | 11.3% | 92 | 223 |
| Off label use | 292 | 9.8% | 75 | 98 |
| Drug ineffective | 253 | 8.5% | 63 | 60 |
| Pneumonia | 243 | 8.2% | 120 | 98 |
| Myelosuppression | 233 | 7.8% | 30 | 93 |
| Product use in unapproved indication | 195 | 6.5% | 59 | 17 |
| Neutropenia | 193 | 6.5% | 64 | 69 |
| Sepsis | 175 | 5.9% | 99 | 81 |
| Acute myeloid leukaemia | 172 | 5.8% | 92 | 52 |
| Thrombocytopenia | 170 | 5.7% | 31 | 50 |
| Disease progression | 156 | 5.2% | 55 | 33 |
| Death | 140 | 4.7% | 139 | 25 |
| Pyrexia | 137 | 4.6% | 22 | 104 |
| Infection | 126 | 4.2% | 55 | 23 |
| Nausea | 118 | 4.0% | 18 | 36 |
Other Indications for DECITABINE
Acute myeloid leukaemia (1,400)
Myelodysplastic syndrome (429)
Product used for unknown indication (253)
Acute myeloid leukaemia refractory (71)
Chemotherapy (70)
Chronic myelomonocytic leukaemia (67)
Acute lymphocytic leukaemia (54)
Acute myeloid leukaemia recurrent (49)
Myeloid leukaemia (49)
Myeloproliferative neoplasm (37)
Other Drugs Used for Bone marrow conditioning regimen
FLUDARABINE (6,080)
BUSULFAN (4,669)
CYCLOPHOSPHAMIDE (4,485)
MELPHALAN (2,368)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (1,884)
THIOTEPA (1,551)
ALEMTUZUMAB (1,122)
ETOPOSIDE (936)
CYTARABINE (833)
THYMOCYTE IMMUNE GLOBULIN NOS (742)